Photographer: Kiyoshi Ota/Bloomberg

CVS Cuts Coverage of Dozens of Drugs in Exclusion Expansion

  • Benefit manager to exclude some cancer, diabetes treatments
  • Company cites ‘hyperinflationary’ increases on 10 drugs

CVS Health Corp. will add 35 products to its lists of excluded drugs in 2017 and no longer cover some treatments for cancer and diabetes, in an aggressive move to favor lower-priced treatments and target what the company called “hyperinflation” of some other products.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.